Literature DB >> 11742995

Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.

I Kitabayashi1, Y Aikawa, L A Nguyen, A Yokoyama, M Ohki.   

Abstract

The AML1-CBF beta transcription factor complex is the most frequent target of specific chromosome translocations in human leukemia. The MOZ gene, which encodes a histone acetyltransferase (HAT), is also involved in some leukemia-associated translocations. We report here that MOZ is part of the AML1 complex and strongly stimulates AML1-mediated transcription. The stimulation of AML1-mediated transcription is independent of the inherent HAT activity of MOZ. Rather, a potent transactivation domain within MOZ appears to be essential for stimulation of AML1-mediated transcription. MOZ, as well as CBP and MOZ-CBP, can acetylate AML1 in vitro. The amount of AML1-MOZ complex increases during the differentiation of M1 myeloid cells into monocytes/macrophages, suggesting that the AML1-MOZ complex might play a role in cell differentiation. On the other hand, the MOZ-CBP fusion protein, which is created by the t(8;16) translocation associated with acute monocytic leukemia, inhibits AML1-mediated transcription and differentiation of M1 cells. These results suggest that MOZ-CBP might induce leukemia by antagonizing the function of the AML1 complex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742995      PMCID: PMC125775          DOI: 10.1093/emboj/20.24.7184

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

1.  A novel cofactor for p300 that regulates the p53 response.

Authors:  N Shikama; C W Lee; S France; L Delavaine; J Lyon; M Krstic-Demonacos; N B La Thangue
Journal:  Mol Cell       Date:  1999-09       Impact factor: 17.970

2.  Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation.

Authors:  I Kitabayashi; Y Aikawa; A Yokoyama; F Hosoda; M Nagai; N Kakazu; T Abe; M Ohki
Journal:  Leukemia       Date:  2001-01       Impact factor: 11.528

3.  Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13).

Authors:  I Panagopoulos; T Fioretos; M Isaksson; U Samuelsson; R Billström; B Strömbeck; F Mitelman; B Johansson
Journal:  Hum Mol Genet       Date:  2001-02-15       Impact factor: 6.150

4.  A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia.

Authors:  B Lutterbach; J J Westendorf; B Linggi; S Isaac; E Seto; S W Hiebert
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

5.  The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase.

Authors:  N Champagne; N Pelletier; X J Yang
Journal:  Oncogene       Date:  2001-01-18       Impact factor: 9.867

6.  Crystal structure of globular domain of histone H5 and its implications for nucleosome binding.

Authors:  V Ramakrishnan; J T Finch; V Graziano; P L Lee; R M Sweet
Journal:  Nature       Date:  1993-03-18       Impact factor: 49.962

Review 7.  Chromosomal translocations in human cancer.

Authors:  T H Rabbitts
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

8.  Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor.

Authors:  S Wang; Q Wang; B E Crute; I N Melnikova; S R Keller; N A Speck
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation.

Authors:  S Meyers; N Lenny; S W Hiebert
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

10.  Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha.

Authors:  E Ogawa; M Inuzuka; M Maruyama; M Satake; M Naito-Fujimoto; Y Ito; K Shigesada
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

View more
  70 in total

1.  Molecular requirements for gene expression mediated by targeted histone acetyltransferases.

Authors:  Sandra Jacobson; Lorraine Pillus
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 2.  MYST-family histone acetyltransferases: beyond chromatin.

Authors:  Vasileia Sapountzi; Jacques Côté
Journal:  Cell Mol Life Sci       Date:  2010-12-04       Impact factor: 9.261

3.  Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features.

Authors:  Emma Tham; Anna Lindstrand; Avni Santani; Helena Malmgren; Addie Nesbitt; Holly A Dubbs; Elaine H Zackai; Michael J Parker; Francisca Millan; Kenneth Rosenbaum; Golder N Wilson; Ann Nordgren
Journal:  Am J Hum Genet       Date:  2015-02-26       Impact factor: 11.025

4.  De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay.

Authors:  Valerie A Arboleda; Hane Lee; Naghmeh Dorrani; Neda Zadeh; Mary Willis; Colleen Forsyth Macmurdo; Melanie A Manning; Andrea Kwan; Louanne Hudgins; Florian Barthelemy; M Carrie Miceli; Fabiola Quintero-Rivera; Sibel Kantarci; Samuel P Strom; Joshua L Deignan; Wayne W Grody; Eric Vilain; Stanley F Nelson
Journal:  Am J Hum Genet       Date:  2015-02-26       Impact factor: 11.025

5.  CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.

Authors:  John Anto Pulikkan; Mahesh Hegde; Hafiz Mohd Ahmad; Houda Belaghzal; Anuradha Illendula; Jun Yu; Kelsey O'Hagan; Jianhong Ou; Carsten Muller-Tidow; Scot A Wolfe; Lihua Julie Zhu; Job Dekker; John Hackett Bushweller; Lucio Hernán Castilla
Journal:  Cell       Date:  2018-06-28       Impact factor: 41.582

Review 6.  Leukaemogenesis: more than mutant genes.

Authors:  Jianjun Chen; Olatoyosi Odenike; Janet D Rowley
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

Review 7.  Posttranslational modifications of RUNX1 as potential anticancer targets.

Authors:  S Goyama; G Huang; M Kurokawa; J C Mulloy
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

8.  MOZ increases p53 acetylation and premature senescence through its complex formation with PML.

Authors:  Susumu Rokudai; Oleg Laptenko; Suzzette M Arnal; Yoichi Taya; Issay Kitabayashi; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

9.  Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells.

Authors:  Tim Thomas; Lynn M Corcoran; Raffi Gugasyan; Mathew P Dixon; Thomas Brodnicki; Stephen L Nutt; Donald Metcalf; Anne K Voss
Journal:  Genes Dev       Date:  2006-05-01       Impact factor: 11.361

10.  Changes in global gene expression during in vitro decidualization of rat endometrial stromal cells.

Authors:  Griselda Vallejo; Darío Maschi; Ana C Mestre-Citrinovitz; Kazuhiro Aiba; Ricardo Maronna; Victor Yohai; Minoru S H Ko; Miguel Beato; Patricia Saragüeta
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.